show trials

Show trial

show trials

The Show and the Trial The Political Death of Milošević

Trastuzumab Trials Steal Show at ASCO Meeting

Agents Targeting Apoptosis Show Promise in Early Trials

Costs Studies Show Clinical Trials, Standard Therapy May Be Equal

Breast Cancer Prevention Trial Shows Major Benefit, Some Risk

New Data on Clinical Trials Directive in Europe Show Few Favorable Outcomes

A Prospective Cross-Over Field Trial Shows Protection of Lemon Eucalyptus Extract Against Tick Bites

A prospective randomized multicenter trial shows improvement of sternum related complications in cardiac surgery with the Posthorax® support vest☆

Results from two pharmacotherapy trials show alcoholic smokers were more severely alcohol dependent but less prone to relapse than alcoholic non-smokers

Low back pain symptoms show a similar pattern of improvement following a wide range of primary care treatments: a systematic review of randomized clinical trials

Do patients undergoing renal revascularization outside of the ASTRAL trial show any benefit? Results of a single-centre observational study

FP398VIRTUAL CLINICAL TRIAL OF CINACALCET IN HEMODIALYSIS PATIENTS SHOWS PROFOUND IMPACT OF PATIENT ADHERENCE ON PARATHYROID HORMONE LEVELS

LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY

OP015. Multicentre clinical trial with topical administration of the Toll-Like receptor 9 agonist DIMS0150 shows evidence for efficacy in moderate to severe Ulcerative Colitis

Randomized placebo-controlled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding

P2540Results of a blind, randomized, placebo-controlled trial show feasibility and efficacy of adventitial progenitor cell transplantation in a swine model of reperfused myocardial infarction

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial